Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed
InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is…
InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is…
S100P Gene Expression May Be Marker of Anti-Tumor Activity in Pancreatic Cancer In Vivo Models…
The global hair restoration market is expected to reach $13.6 billion by 2028 LOS ANGELES, March 08,…
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
MINNEAPOLIS, March 08, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
March 20, 2023 at 11:00 AM ET PORTLAND, Maine, March 08, 2023 (GLOBE NEWSWIRE) —…
Topline Data Expected in 2Q 2023 SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2023…
OV350 is the first reported compound that directly binds to and activates the KCC2 co-transporter,…
FDA recommends additional revised primary symptom-based endpoints Revive to provide amended statistical analysis plan to…
Recent upgrades lead to testing results that show customers in El Paso have the best…
Recent upgrades lead to testing results that show customers in Greenville have the best experience…
FORT LAUDERDALE, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Netsurion, a leading provider of Managed…
SANTA CLARA, Calif., March 08, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…
Economic uncertainty refocuses priorities and challenges on cloud costs, and AI experimentation is significant ITASCA,…
Come see the Eclipse Foundation and Zettascale in Hall 4, Booth 4-554 BRUSSELS, Belgium, March…
Expansion of first-phase deployment follows excellent published results, showing cross-cultural validity, leading to further expansion…
The Display Is Being Constructed In Arizona With A Greenhouse And Several Full Sized Windows…
New Space Offers Advanced Development Capabilities for the PREVA (TM) Clot Removal Device for Ischemic…
Toronto, Ontario–(Newsfile Corp. – March 8, 2023) – Xigem Technologies Corporation (CSE: XIGM) (FSE: VZ6)…